Monday, June 05, 2017 3:55:51 PM
“Currently, the ACMPR is limited to oils that are liquid at room temperature. That’s all you have right now. But the ability to work with other forms outside of the ACMPR but under a GMP license provides companies who have access to this, like Canopy Health, the ability to work on different formulations, different delivery systems that allow us to try to advance medical cannabis products to another level, a next generation essentially."
https://news.lift.co/canopy-health-innovations-marc-wayne-future-medical-cannabis/
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM